ATE256751T1 - Monoklonaler anti-hiv antikörper - Google Patents

Monoklonaler anti-hiv antikörper

Info

Publication number
ATE256751T1
ATE256751T1 AT94909286T AT94909286T ATE256751T1 AT E256751 T1 ATE256751 T1 AT E256751T1 AT 94909286 T AT94909286 T AT 94909286T AT 94909286 T AT94909286 T AT 94909286T AT E256751 T1 ATE256751 T1 AT E256751T1
Authority
AT
Austria
Prior art keywords
region
antibody
hiv
pnd
monoclonal antibody
Prior art date
Application number
AT94909286T
Other languages
English (en)
Inventor
Yasuyuki Eda
Hiroaki Maeda
Keiichi Makizumi
Kouichi Shiosaki
Kiyoshi Osatomi
Kazuhiko Kimachi
Hirofumi Higuchi
Sachio Tokiyoshi
Original Assignee
Chemo Sero Therapeut Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeut Res Inst filed Critical Chemo Sero Therapeut Res Inst
Application granted granted Critical
Publication of ATE256751T1 publication Critical patent/ATE256751T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036Retroviridae, e.g. leukemia viruses
    • C07K16/1045Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1063Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT94909286T 1993-03-11 1994-03-09 Monoklonaler anti-hiv antikörper ATE256751T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7891393 1993-03-11
PCT/JP1994/000371 WO1994020632A1 (en) 1993-03-11 1994-03-09 Anti-hiv monoclonal antibody

Publications (1)

Publication Number Publication Date
ATE256751T1 true ATE256751T1 (de) 2004-01-15

Family

ID=13675093

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94909286T ATE256751T1 (de) 1993-03-11 1994-03-09 Monoklonaler anti-hiv antikörper

Country Status (11)

Country Link
US (1) US6114143A (de)
EP (1) EP0690132B1 (de)
JP (1) JP3855071B2 (de)
KR (1) KR100337069B1 (de)
AT (1) ATE256751T1 (de)
AU (1) AU681633B2 (de)
DE (1) DE69433422T2 (de)
DK (1) DK0690132T3 (de)
ES (1) ES2213148T3 (de)
PT (1) PT690132E (de)
WO (1) WO1994020632A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040234524A1 (en) * 2001-04-05 2004-11-25 Toshimitsu Uede Anti-osteopontin antibody and use thereof
KR100423614B1 (ko) * 2001-05-16 2004-03-22 주식회사유한양행 비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자
CA2461529A1 (en) 2001-09-25 2003-04-03 Immuno-Biological Laboratories Co., Ltd. Recombinant anti-osteopontin antibody and use thereof
CA2466050A1 (en) 2001-11-07 2003-05-15 Duke University Polyvalent immunogen
US7172761B2 (en) * 2001-11-07 2007-02-06 Duke University Polyvalent immunogen
US7195768B2 (en) * 2001-11-07 2007-03-27 Duke University Polyvalent immunogen
US7041499B2 (en) * 2001-12-12 2006-05-09 University Of North Texas Health Science Center Immuno activation of CS1 receptor in natural killer cells to inhibit tumor cell growth
AU2003241296A1 (en) * 2002-04-12 2003-10-27 Mba Polymers, Inc. Compositions of materials containing recycled plastics
US7553926B2 (en) * 2002-04-23 2009-06-30 Andrea Savarino Compositions containing anti-HIV peptides and methods for use
EP1595959B1 (de) * 2003-02-20 2015-01-21 The Chemo-Sero-Therapeutic Research Institute Verfahren zur verstärkung der wirksamkeit eines präparats von monoklonalem antikörper
US20050014230A1 (en) * 2003-07-16 2005-01-20 Ccl Holding Co., Ltd. Preparation of fully human antibodies
WO2005080435A1 (ja) 2004-02-20 2005-09-01 Immuno-Biological Laboratories Co., Ltd. モノクローナル抗体およびその利用
CN101313216A (zh) * 2005-09-22 2008-11-26 普洛茨股份有限公司 酵母突变体中产生的糖基化多肽及其使用方法
JP4064441B2 (ja) 2006-05-31 2008-03-19 アステラス製薬株式会社 ヒト化抗ヒトオステオポンチン抗体
PT2243829E (pt) 2008-01-11 2014-10-24 Astellas Pharma Inc Anticorpo anti-integrina-alfa9 humana humanizado melhorado
US20110300068A1 (en) 2009-01-12 2011-12-08 Takeda Pharmaceutical Company Limited Agent for prophylaxis or treatment of cancer
JP5726165B2 (ja) 2010-03-11 2015-05-27 株式会社 資生堂 アオウキクサ由来の新規リポキシゲナーゼ
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
CN102822337A (zh) 2010-03-31 2012-12-12 株式会社资生堂 来自于稀脉萍的新的丙二烯氧化物合酶
TW201249867A (en) 2011-04-01 2012-12-16 Astellas Pharma Inc Novel anti-human il-23 receptor antibody
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EA024292B1 (ru) 2011-08-11 2016-09-30 Астеллас Фарма Инк. Новое антитело против ngf человека
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2586461A1 (de) 2011-10-27 2013-05-01 Christopher L. Parks Von einem eingehüllten Virus abgeleitete Virenpartikel
JP6040943B2 (ja) 2011-12-22 2016-12-07 アステラス製薬株式会社 新規抗ヒトctgf抗体
ES2701064T3 (es) 2012-02-28 2019-02-20 Astellas Pharma Inc Novedoso anticuerpo antirreceptor IL-23 humano
EP2679596B1 (de) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 Env-proteinvariante
PL3031913T3 (pl) 2013-08-09 2019-08-30 Astellas Pharma Inc. Nowe przeciwciało przeciwko receptorowi ludzkiej tslp
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
RU2016129744A (ru) 2013-12-24 2018-01-30 Астеллас Фарма Инк. Новое антитело против bdca-2 человека
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9925258B2 (en) 2015-10-02 2018-03-27 International Aids Vaccine Initiative Replication-competent VSV-HIV Env vaccines
WO2020010107A1 (en) 2018-07-03 2020-01-09 Gilead Sciences, Inc. Antibodies that target hiv gp120 and methods of use
BR112021002096A2 (pt) 2018-08-20 2021-06-01 Jiangsu Hengrui Medicine Co., Ltd. uso de anticorpos tim-3 na preparação de medicamentos para o tratamento de tumores
CN113423731B (zh) * 2018-10-29 2024-05-14 株式会社免疫生物研究所 抗hiv抗体及其制造方法
IL282650B1 (en) 2018-10-31 2024-05-01 Astellas Pharma Inc Anti-human FN14 antibody

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) * 1986-03-27 1986-04-30 Winter G P Recombinant dna product
ATE122237T1 (de) * 1987-05-29 1995-05-15 Tanox Biosystems Inc Hiv-1 neutralisierende monoklonale antikörper.
EP0339504A3 (de) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Menschliches immunoinsuffizientes Virus (HIV) env-codiertes Peptid, welches im Stande ist, die HIV hemmenden Antikörper bei Säugetieren hervorzurufen
WO1990003984A1 (en) * 1988-10-03 1990-04-19 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
JPH05506561A (ja) * 1989-06-05 1993-09-30 レプリゲン・コーポレーション HIV―1 MN gp120のヒトモノクローナル抗体
DE69227500T2 (de) * 1991-08-22 1999-04-15 Nissin Food Products Ltd In der Therapie von einer HIV-1-Infektion verwendbare monoklonale Antikörper

Also Published As

Publication number Publication date
AU681633B2 (en) 1997-09-04
ES2213148T3 (es) 2004-08-16
PT690132E (pt) 2004-04-30
KR960701214A (ko) 1996-02-24
DE69433422D1 (de) 2004-01-29
EP0690132A4 (de) 1998-07-29
EP0690132A1 (de) 1996-01-03
AU6219494A (en) 1994-09-26
DK0690132T3 (da) 2004-04-13
WO1994020632A1 (en) 1994-09-15
DE69433422T2 (de) 2004-09-16
EP0690132B1 (de) 2003-12-17
KR100337069B1 (ko) 2002-10-11
JP3855071B2 (ja) 2006-12-06
US6114143A (en) 2000-09-05

Similar Documents

Publication Publication Date Title
ATE256751T1 (de) Monoklonaler anti-hiv antikörper
PT100195A (pt) Anticorpos monoclonais quimericos e humanos que se ligam a epitopos de receptores de factor de crescimento da epiderme, seus vectores de expressao, processo de preparacao e composicoes farmaceuticas que os contem
CA2091263A1 (en) Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
PT678523E (pt) Anticorpos recombinantes anti-vih e sua preparacao
KR930702509A (ko) 사람 면역결핍 바이러스(hiv)면역치료제
RU2004108115A (ru) Рекомбинантные антитела и композиции, а также способы их создания и использования
ES2059577T3 (es) Fragmentos genicos que codifican para las regiones variables de un anticuerpo anti-hiv, anticuerpos anti-hiv quimericos expresados utilizando los mismos y procedimiento para su preparacion.
RU94045907A (ru) Вич-антитела человека или их фрагменты, экспрессионные кассеты, клетки-хозяева, фармацевтические композиции, способ защиты
DE69941051D1 (de) Expression und charakterisierung eines hiv-1 hüllproteins, das mit einer breitreaktiven neutralisier
DK0516135T3 (da) Humant immundefektvirus-relateret immunpræparat
KR890016165A (ko) 수도모나스 아에루기노사(Pseudomonas aeruginosa)에 대한 모노클로날 항체, 이의 제조방법 및 용도
EP0511300A1 (de) Monoklonaler antikörper mit spezifität für nichtimmundominantes epitop des hiv-proteins
CA2157874A1 (en) Anti-hiv monoclonal antibody
RU2007140569A (ru) Антитело или его фрагмент, имеющие нейтрализующую активность в отношении вич, но не в отношении il2
DE69113520D1 (de) Monoklonale Antikörper gegen HIV GP120.
Huang et al. A predefined epitope-specific monoclonal antibody recognizes ELDEWA-epitope just presenting on gp41 of HIV-1 O clade
RU2021136626A (ru) АНТИТЕЛО К EphA4
RU2007140570A (ru) Антитело или его фрагмент, имеющие нейтрализующую активность в отношении вич
DE68913932T2 (de) Arzneimittel für die Behandlung oder die Verhütung von Infektionen mit HIV durch Immunisierung, und Verfahren zur Herstellung.
KR20040000401A (ko) Hiv 바이러스에 대한 천연 항체
KR960700274A (ko) 재조합 항-hiv 항체 및 그의 제조방법[recombinant anti-hiv antibody and preparation thereof]
BR9711809A (pt) Polipeptìdeo antigênico ou imunogênico, processos para tratar ou prevenir uma doença ou distúrbio em um indivìduo provocado por infecção com htlv-i, e com htlv-ii, para elicitar em um indivìduo a produção de anticorpos que especificamente ligam-se às proteìnas envelopes htlv-ii e htlv-i, e, para gerar uma resposta imune em um indivìduo
RU93004854A (ru) Пептиды для вакцинации и индукции нейтрализующих антител против вируса иммунодефицита человека

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0690132

Country of ref document: EP

REN Ceased due to non-payment of the annual fee